Heart drugs free from carcinogens identified as recalls drag on
The Food and Drug Administration has released a list of 40 drugs used to treat hypertension and heart failure that don’t contain any known carcinogens...
List view / Grid view
The Food and Drug Administration has released a list of 40 drugs used to treat hypertension and heart failure that don’t contain any known carcinogens...
Disposable injectors are the most commonly available type of injectors since they are user friendly and do not require special skills for administration...
The FDA has prioritised the review of this drug application after multiple recalls of generic valsartan products from several manufacturers...
The generic version will cost 50 percent less that the current Humalog list price...
The pharmaceutical drug delivery market could reach $1,694.7 billion by 2023, increasing at a CAGR of 6.4 percent during the period...
The CMA provisionally finds Auden Mckenzie and Waymade broke the law by agreeing not to compete for the supply of hydrocortisone tablets to the NHS...
Campaigners call for UK Government to intervene on pricing dispute over cystic fibrosis drug Orkambi...
Results did not confirm the clinical benefit of Lartruvo in combination with doxorubicin compared to doxorubicin alone…
A generic version of the seizure drug Sabril (vigabatrin) has been approved by the FDA...
Chairman of the Committee on Oversight and Reform sends detailed requests to 12 pharmaceutical companies about increasing drug prices...
Medical marketing increased substantially from 1997 through 2016, especially direct-to-consumer advertising for drugs and health services…
The pharma corridor between Hong Kong and Brussels Airport assures handling quality for temperature-sensitive pharmaceuticals.
The rising costs of brand-name drugs is largely driven by inflation in the prices of widely used existing drugs, according to a study published in the January issue of Health Affairs...
Innovators should be able to get products to the UK market as quickly and simply as possible, according to the Medicines and Healthcare products Regulatory Agency...
Eurofins BioPharma Product Testing expands its footprint of GMP testing laboratories with recent acquisitions, including Astellas Analytical Science Laboratories, Inc. (ASL) in Japan, PHAST Gesellschaft für Pharmazeutische Qualitätsstandards mbH (PHAST) in Germany, and Bactup in France...